血液透析患者中 SARS-CoV-2 的血清流行率。
The seroprevalence of SARS-CoV-2 in patients on haemodialysis.
机构信息
Department of Renal Medicine, Barts Health NHS Trust, London, UK.
Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
出版信息
Nat Rev Nephrol. 2021 Apr;17(4):225-226. doi: 10.1038/s41581-020-00379-y.
Abstract
A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution.
摘要
一项新的研究报告了血液透析患者中 SARS-CoV-2 抗体的血清阳性率，并利用这些数据来估计美国普通人群中的血清阳性率。尽管这项研究表明了在透析人群中监测传染病流行情况的潜力，但研究结果应谨慎解释。
相似文献
1
The seroprevalence of SARS-CoV-2 in patients on haemodialysis.血液透析患者中 SARS-CoV-2 的血清流行率。
Nat Rev Nephrol. 2021 Apr;17(4):225-226. doi: 10.1038/s41581-020-00379-y.
2
SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.美国接受透析治疗患者中新冠病毒 2 型抗体血清流行率
Lancet. 2020 Oct 24;396(10259):1308-1309. doi: 10.1016/S0140-6736(20)32006-7. Epub 2020 Sep 25.
3
Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms.接受血液透析的患者接种新冠疫苗后针对S1刺突蛋白抗体的血清流行率：紧急呼吁
Kidney Int. 2021 Jun;99(6):1492-1494. doi: 10.1016/j.kint.2021.04.008. Epub 2021 Apr 20.
4
Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom.调查 COVID-19 抗体检测在接受血液透析的终末期肾病患者中的效用：英国的一项队列研究。
BMC Nephrol. 2021 Apr 27;22(1):154. doi: 10.1186/s12882-021-02366-2.
5
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.2020 年 4 月伊朗吉兰省 SARS-CoV-2 的血清流行率。
Emerg Infect Dis. 2021 Feb;27(2):636-638. doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.
6
Prevalence of COVID-19 and seroprevalence to SARS-CoV-2 in a rheumatologic patient population from a tertiary referral clinic in Israel.以色列一家三级转诊诊所的风湿科患者人群中 COVID-19 的流行情况和对 SARS-CoV-2 的血清流行率。
Intern Med J. 2021 May;51(5):682-690. doi: 10.1111/imj.15202. Epub 2021 May 12.
7
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.2020 年 8 月至 9 月印度 SARS-CoV-2 抗体血清阳性率：第二次全国家庭血清学调查结果。
Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27.
8
Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).2020 年 5 月至 7 月葡萄牙 SARS-CoV-2 感染的血清阳性率：首次全国血清学调查（ISNCOVID-19）的结果。
Acta Med Port. 2021 Feb 1;34(2):87-94. doi: 10.20344/amp.15122.
9
National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.全国范围内对 114 万 NHS 员工进行的 SARS-CoV-2 血清学检测的横断面调查：NHS 员工与区域社区血清转化率的比较。
BMJ Open. 2021 Jul 13;11(7):e049703. doi: 10.1136/bmjopen-2021-049703.
10
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.加拿大第一波 COVID-19 疫情后献血者中的 SARS-CoV-2 血清流行率。
Transfusion. 2021 Mar;61(3):862-872. doi: 10.1111/trf.16296. Epub 2021 Feb 23.
本文引用的文献
1
gene.iobio: an interactive web tool for versatile, clinically-driven variant interrogation and prioritization.Gene.iobio：一款用于多功能、临床驱动的变异体查询和优先级排序的交互式网络工具。
medRxiv. 2020 Nov 6:2020.11.05.20224865. doi: 10.1101/2020.11.05.20224865.
Zotero 插件